Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference |
| [19-December-2025] |
SECAUCUS, N.J., Dec. 19, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading national provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance, and the latest market developments and trends during a presentation and Q&A session at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 4:30 p.m. Pacific Time. The presentation and Q&A session will be webcast live during the conference and will be available at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 11, 2026. About Quest Diagnostics
SOURCE Quest Diagnostics | ||
Company Codes: NYSE:DGX |












